Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.

Nature biotechnology - 1 Aug 2006

Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert

Abstract excerpt

Among all the known differences between cancer and normal cells, it is only the genetic differences that unequivocally distinguish the former from the latter. It is therefore not surprising that recent therapeutic advances are based on agents that specifically target the products of the genes tha...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Gene Targeting
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genetic Therapy

Share to Molecular Diagnostic Techniques

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 16900147
DOI: 10.1038/nbt1234

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16900147-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.PMID 16900147Read ↗

Mutation detection and molecular targeted tumor therapiesSemantic proximity Read ↗

Companion diagnostic testing for targeted cancer therapies: an overview.Semantic proximity Read ↗

Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.Semantic proximity Read ↗

The molecular basis of cancer and the development of targeted therapy.Semantic proximity Read ↗

Market watch: emerging companion diagnostics for cancer drugs.Semantic proximity Read ↗

Molecular methods in cancer diagnostics: a short review.Semantic proximity Read ↗

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.Semantic proximity Read ↗

Molecular methods for the diagnosis of cancer.Semantic proximity Read ↗

Present and future of cancer biomarkersSemantic proximity Read ↗

Targeting mutations in cancer.Semantic proximity Read ↗

Get the basics of genetic mutations in oncology.Semantic proximity Read ↗

Passenger mutations as a target for the personalized therapy of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.